Gwrthrychau elusennol
(A) THE RELIEF OF SICKNESS AND THE PROTECTION AND PRESERVATION OF THE HEALTH OF PERSONS AFFECTED BY DYSKERATOSIS CONGENITA AND ANY RELATED CONDITION AND THEIR FAMILIES AND CARERS IN PARTICULAR BY BUT NOT RESTRICTED TO;
(B) THE ADVANCEMENT OF THE EDUCATION OF THE MEDICAL PROFESSION AND THE GENERAL PUBLIC INTO DYSKERATOSIS CONGENITA AND ITS IMPLICATIONS FOR THE FAMILY.
(C) THE PROMOTION F RESEARCH INTO THE CAUSES, EFFECTS, TREATMENT AND MANAGEMENT OF DYSKERATOSIS CONGENITA AND TO DISSEMINATE THE USEFUL RESULTS THEREOF.
